Sales rise 42.65% to Rs 22.11 crore
Net profit of Indo US Bio-Tech rose 168.61% to Rs 3.68 crore in the quarter ended December 2023 as against Rs 1.37 crore during the previous quarter ended December 2022. Sales rose 42.65% to Rs 22.11 crore in the quarter ended December 2023 as against Rs 15.50 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales22.1115.50 43 OPM %19.1313.23 -PBDT3.941.64 140 PBT3.751.35 178 NP3.681.37 169Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
